Exchange Announcement • 14 Oct 2025 17:44
Exchange Announcement • 14 Oct 2025 14:33
Exchange Announcement • 24 Sep 2025 20:01
Exchange Announcement • 17 Sep 2025 20:01
Exchange Announcement • 15 Sep 2025 20:00
Search or
𝛼SK
𝛼SKENTITY
Mezzion Pharma (140410 KS)
Mezzion Pharma (140410 KS)
16
Analysis
Health Care • South Korea
Mezzion Pharma Co Ltd develops pharmaceutical products and out-licenses them to foreign countries including Canada, Mexico, Russia, and the United States. The Company's main products are for benign prostatic hyperplasia and erectile dysfunction.
morex